0.0372	0.9525	OMIM:231090	HYDATIDIFORM MOLE	NLRP7	199713
0.0372	0.9525	OMIM:305690	GENITOURINARY TRACT ANOMALIES		
0.0372	0.9525	OMIM:600171	GONADAL AGENESIS		
0.0372	0.9525	OMIM:191600	URETER, CANCER OF		
0.0372	0.9525	OMIM:149600	LABIA MINORA, INCOMPLETE ADHESION OF		
0.0372	0.9525	OMIM:191800	URINARY BLADDER, ATONY OF		
0.0497	1.8589	OMIM:260800	PENTOSURIA	DCXR	51181
0.0497	0.9439	OMIM:191020	TROPHOBLAST-LYMPHOCYTE CROSSREACTIVE ANTIGEN		
0.0497	0.9439	OMIM:154230	SEX REVERSAL, AUTOSOMAL, 2		
0.0670	2.2212	OMIM:613159	#613159 NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1	XPNPEP3	63929
0.1422	1.6626	ORPHANET:293355	METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA		
0.1490	1.8936	ORPHANET:2666	ADULT FAMILIAL NEPHRONOPHTISIS - SPASTIC QUADRIPARESIA		
0.2831	2.0908	ORPHANET:84090	FIBRONECTIN GLOMERULOPATHY	FN1	2335
0.2831	2.0029	OMIM:607832	#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	CD2AP	23607
0.2831	1.3861	ORPHANET:2675	NEUROAXONAL DYSTROPHY - RENAL TUBULAR ACIDOSIS		
0.4749	2.0750	OMIM:603965	#603965 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 2	TRPC6	7225
0.4931	2.3188	OMIM:611771	#611771 LIPOPROTEIN GLOMERULOPATHY; LPG	APOE	348
0.4931	2.2526	OMIM:613237	#613237 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 5	INF2	64423
0.4931	1.8998	OMIM:614131	#614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	MYO1E	4643
0.4931	1.7148	OMIM:613364	%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41		
